New frontiers in transarterial chemoembolization: Combination with systemic therapies

Rafael Duran, Thierry de Baere, Lambros Tselikas

    Résultats de recherche: Le chapitre dans un livre, un rapport, une anthologie ou une collection!!ChapterRevue par des pairs

    Résumé

    Transarterial chemoembolization (TACE) is one of the treatment most frequently used in patients with liver cancer, in particular hepatocellular carcinoma (HCC). Although the survival of patients treated by TACE has markedly improved over the last decades, the prognosis remains poor. Systemic treatment of HCC has become the focus of intensive research with combination of immunotherapies, tyrosine kinase inhibitors and antiangiogenic drugs. TACE combined with systemic therapies, such as in particular immunotherapies, have the potential to improve outcomes. Here we present the rationale for such combination and provide an overview of clinical achievements and ongoing research in this field.

    langue originaleAnglais
    titreTransarterial Chemoembolization (TACE)
    EditeurSpringer International Publishing
    Pages107-117
    Nombre de pages11
    ISBN (Electronique)9783031362613
    ISBN (imprimé)9783031362606
    Les DOIs
    étatPublié - 9 oct. 2023

    Contient cette citation